Lumira Capital Investment Management Inc - Company Review
Lumira Capital Investment Management Inc - Company ReviewSummary
Lumira Capital Investment Management Inc (Lumira Capital), formerly MDS Capital Corp, is a financial service provider that offers venture capital and investment services. The company provides investment in later stage biopharmaceutical and medical device companies having preliminary clinical safety and proof of concept data and revenue generation. It develops and implements strategies to build businesses which generate profitable exit opportunities for health care and life science companies. Lumira Capital's investment portfolio includes Celtaxsys Inc, Carrot Insights, Exact Imaging, Gladius Pharmaceuticals, G1 Therapeutics, Formation Biologics, First Aid Shot Therapy, Argos Therapeutics, Aurinia Pharmaceuticals, BAROnova and Cardiac Dimensions, among others. The company has operations across the US and Canada. Lumira Capital is headquartered in Toronto, Ontario, Canada.
This comprehensive company report of Lumira Capital Investment Management Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.